Extracorporeal Membrane Oxygenation Machine Market worth $1,085.63 million by 2030, growing at a CAGR of 4.55% - Exclusive Report by 360iResearch

The "Extracorporeal Membrane Oxygenation Machine Market by Modality (Arteriovenous ECMO, Venoarterial ECMO, Venovenous ECMO), Age (Adult, Neonate, Pediatric), Component, Application, End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Extracorporeal Membrane Oxygenation Machine Market to grow from USD 794.86 million in 2023 to USD 1,085.63 million by 2030, at a CAGR of 4.55%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/extracorporeal-membrane-oxygenation-machine?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Extracorporeal membrane oxygenation machines are medical devices that provide prolonged cardiac & respiratory support for patients whose hearts and lungs cannot provide adequate gas exchange to sustain life. These machines extract blood from the patient's body, oxygenate it through an artificial lung (the membrane), remove carbon dioxide, and then return it to the patient's bloodstream. This external life support system takes over the function of the heart and lungs, allowing these organs to rest and heal during critical illness. The surging prevalence of cardiovascular and respiratory diseases and technological advancements that improve patient outcomes have increased the adoption of ECMO systems. Additionally, improvements in healthcare infrastructure and increased healthcare spending are contributing to the market expansion. High costs associated with ECMO procedures and a limited number of trained healthcare professionals to operate these machines represent a challenge for market growth. Nevertheless, advancements in ECMO machine design to enhance portability and ease of use in different treatment settings are expected to provide opportunistic scope for the market. Moreover, ECMO integration with other extracorporeal therapies and research activities focused on expanding the indications for ECMO support is expected to boost the market.

In the Americas region, extracorporeal membrane oxygenation machines have seen significant growth driven by the high incidence rates of cardiovascular and respiratory diseases, a well-established healthcare infrastructure system, and the availability of skilled professionals. Additionally, the region has seen a surge in ECMO utilization due to the COVID-19 pandemic, further fueling market expansion. Increased funding for research and development, coupled with technological advancements, continues to enhance ECMO system capabilities, making them more efficient and user-friendly for critical care adoption. The market landscape for ECMO machines in the EMEA region exhibits steady growth. In Europe, the demand for ECMO support is influenced by rising healthcare expenditures, an aging population, and the prevalence of lifestyle-associated diseases. Major economies are implementing ECMOs due to their advanced healthcare systems and policies that favor adopting medical devices. The Asia-Pacific region shows high-growth prospects for ECMO machines. Economic development, increasing healthcare expenditure, and a growing population base are pivotal forces propelling market growth. Major economies are investing heavily in upgrading their healthcare infrastructure. Moreover, the boosting medical tourism industry in some economies is also opening new avenues for the ECMO machines market.

Market Segmentation & Coverage:

This research report categorizes the Extracorporeal Membrane Oxygenation Machine Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Modality, market is studied across Arteriovenous ECMO, Venoarterial ECMO, and Venovenous ECMO. The Venoarterial ECMO commanded largest market share of 45.59% in 2023, followed by Venovenous ECMO.

Based on Age, market is studied across Adult, Neonate, and Pediatric. The Adult commanded largest market share of 77.29% in 2023, followed by Neonate.

Based on Component, market is studied across Anticoagulation Systems, Blender, Cannulae, Heat Exchanger, Monitoring Systems, Oxygenator, and Pump. The Anticoagulation Systems commanded largest market share of 17.28% in 2023, followed by Oxygenator.

Based on Application, market is studied across Cardiac Application, Extracorporeal Cardiopulmonary Resuscitation, and Respiratory Application. The Cardiac Application commanded largest market share of 47.55% in 2023, followed by Respiratory Application.

Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics. The Hospitals commanded largest market share of 58.57% in 2023, followed by Specialty Clinics.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 39.09% in 2023, followed by Americas.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/extracorporeal-membrane-oxygenation-machine?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Extracorporeal Membrane Oxygenation Machine Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Extracorporeal Membrane Oxygenation Machine Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Extracorporeal Membrane Oxygenation Machine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abiomed, Inc., Baxter International Inc., Braile Biomédica, Chalice Medical Ltd., CytoSorbents Corporation, Dragerwerk AG & Co. KGaA, Eurosets S.R.L., Getinge AB, Guangdong Pigeon Medical Apparatus Co.,Ltd., Hengko Technology Co., Ltd., Inspira Technologies OXY B.H.N. Ltd., LivaNova PLC, MC3 Cardiopulmonary, Medtronic PLC, MicroPort Scientific Corporation, Nipro Corporation, Origen Biomedical, Inc., Owgels Group, Senko Medical Instrument Mfg. Co., Ltd., Shenzhen Mindray Biomedical Electronics Co. Ltd., Technimount System, Terumo Corporation, XENIOS AG by Fresenius Medical Care AG & Co. KGaA, and ZOLL Medical Corporation by Asahi Kasei Corporation.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Extracorporeal Membrane Oxygenation Machine Market, by Modality
7. Extracorporeal Membrane Oxygenation Machine Market, by Age
8. Extracorporeal Membrane Oxygenation Machine Market, by Component
9. Extracorporeal Membrane Oxygenation Machine Market, by Application
10. Extracorporeal Membrane Oxygenation Machine Market, by End-User
11. Americas Extracorporeal Membrane Oxygenation Machine Market
12. Asia-Pacific Extracorporeal Membrane Oxygenation Machine Market
13. Europe, Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market
14. Competitive Landscape
15. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Extracorporeal Membrane Oxygenation Machine Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Extracorporeal Membrane Oxygenation Machine Market?
3. What is the competitive strategic window for opportunities in the Extracorporeal Membrane Oxygenation Machine Market?
4. What are the technology trends and regulatory frameworks in the Extracorporeal Membrane Oxygenation Machine Market?
5. What is the market share of the leading vendors in the Extracorporeal Membrane Oxygenation Machine Market?
6. What modes and strategic moves are considered suitable for entering the Extracorporeal Membrane Oxygenation Machine Market?

Read More @ https://www.360iresearch.com/library/intelligence/extracorporeal-membrane-oxygenation-machine?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.